Azathioprine and biological treatment genetic association with clinical response and toxicity in inflammatory bowel disease patients.

Mohamed Abdelrahim; Nashwa Eltantawy; Amira Kassem; Islam Abd El-Hamid Elzayyadi; Ahmed Elberry; Layla Salah

doi:10.21608/bfsa.2023.175286.1580

Q4 2023

Azathioprine and biological treatment genetic association with clinical response and toxicity in inflammatory bowel disease patients.

Mohamed Abdelrahim · Nashwa Eltantawy · Amira Kassem · Islam Abd El-Hamid Elzayyadi · Ahmed Elberry · Layla Salah

10.21608/bfsa.2023.175286.1580 386 Views 0 Citations

Citations

386

Views

Abstract not available for this publication.

Cite this Article (APA)

Mohamed, A., Nashwa, E., Amira, K., Islam, A. E. E., Ahmed, E., Layla, S. (2023). Azathioprine and biological treatment genetic association with clinical response and toxicity in inflammatory bowel disease patients.. Bulletin of Pharmaceutical Sciences Assiut. https://doi.org/10.21608/bfsa.2023.175286.1580